Late (&gt;7 days) postnatal corticosteroids for chronic lung disease in preterm infants (Q24241502)

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Pulse dexamethasone does not impair growth and body composition of very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Dexamethasone therapy increases infection in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Early versus late dexamethasone treatment in preterm infants at risk for chronic lung disease: a randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Growth retardation after dexamethasone administration: assessment by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

The influence of betamethasone and dexamethasone on motor development in young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Clinical trials of postnatal corticosteroids: inhaled and systemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

A three year follow up of preterm infants after moderately early treatment with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Using cerebral palsy data in the evaluation of neonatal intensive care: a warning

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

A pilot study assessing inhaled budesonide in chronically oxygen-dependent infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Influence of postnatally administered glucocorticoids on rat lung growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021

Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001145.PUB2

7 January 2021